Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank68
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P68
Within normal range
vs 2Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.62% |
| Q2 2025 | -5.61% |
| Q1 2025 | 22.74% |
| Q4 2024 | 1.41% |
| Q3 2024 | 31.56% |
| Q2 2024 | 5.83% |
| Q1 2024 | 14.40% |
| Q4 2023 | -64.19% |
| Q3 2023 | 9.59% |
| Q2 2023 | -18.68% |
| Q1 2023 | 10.97% |
| Q4 2022 | 7.94% |
| Q3 2022 | -35.15% |
| Q2 2022 | 1.86% |
| Q1 2022 | -1.64% |
| Q4 2021 | 43.41% |
| Q3 2021 | -14.04% |
| Q2 2021 | -176.10% |
| Q1 2021 | -34.88% |
| Q4 2020 | 16.85% |
| Q3 2020 | -43.92% |
| Q2 2020 | 28.59% |
| Q1 2020 | 0.00% |